Eva van Rooij

Heart Failure & Transplant

Hubrecht Institute for Developmental Biology and Stem Cell Research

About

Eva van Rooij works in Heart Failure & Transplant affiliated with Hubrecht Institute for Developmental Biology and Stem Cell Research.

Eva van Rooij is a group leader at the Hubrecht Institute and a professor of Molecular Cardiology at the University Medical Center Utrecht. Her research focuses on unveiling molecular signaling pathways relevant for cardiac disease using mouse genetics and sequencing technologies. She is the founder and Chief Scientific Officer of Phlox Therapeutics.

Research focus

MicroRNA regulation in cardiac diseaseCardiac fibrosis and remodelingSignaling pathways in heart failureNon-coding RNA therapeutics for cardiovascular diseasesMolecular mechanisms of cardiac repair

Impact

148 pubs · 18,560 cites · h-index 55

Training

PhD
Maastricht University
2004
MSc in Health Sciences
Maastricht University
2001

Affiliations

Work Experience

Professor of Molecular Cardiology

University Medical Center Utrecht · 2016 - Present

Group Leader

Hubrecht Institute · 2013 - Present

Director of Biology

miRagen Therapeutics · 2009 - 2011

Instructor

University of Texas Southwestern Medical Center · 2007 - 2009

Postdoctoral Researcher

University of Texas Southwestern Medical Center · 2005 - 2007